Skip to main content
Clinical Trials/NCT04369911
NCT04369911CompletedNot Applicable

Acupuncture Treatment for Chronic Post-traumatic Headache in Individuals With Mild Traumatic Brain Injury

HealthPartners Institute1 site in 1 country39 target enrollmentStarted: November 23, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
39
Locations
1
Primary Endpoint
Change in Number of Headache Days

Study Overview

Brief Summary

The purpose of the study is to determine the effect of a low vs. high dose of acupuncture treatment in individuals with chronic post-traumatic headache (CPTH). A total of 36 people with mild traumatic brain injury (mTBI) suffering from CPTH will be enrolled in this study to receive acupuncture treatment for 5 weeks. Participants will be randomized into two groups: 1) Low Acupuncture group (5 treatments) and 2) High Acupuncture group (10 treatments). It is hypothesized that both treatment groups will have decreased headaches, but that 10 treatments will greater alleviate headaches when compared to 5 treatments.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Ability to provide and provision of signed and dated informed consent form
  • •Age 18-65
  • •Diagnosis of mild traumatic brain injury (mTBI) (as defined by the International classification of headache disorders 3rd edition (ICHD-3); a. Either no loss of consciousness, or loss of consciousness of <30 minutes duration, b. Glascow Coma Scale (GCS) ≥ 13, and c. Symptoms and/or signs diagnostic of concussion)
  • •Diagnosis of mTBI ≥3 months and ≤12 months at the time of study enrollment
  • •Suffering from chronic post-traumatic headache (CPTH) of any etiology (e.g. tension or migraine), with chronic defined as developed within 7 days after injury and lasting ≥3 months from the time of injury
  • •Stable medication regimen for ≥1 months and agree to adhere to his or her current medication treatment regimen through study participation

Exclusion Criteria

  • •Non-English speaking
  • •History of acupuncture since diagnosis of mTBI
  • •History of pre-existing primary headache, defined as more than 12 days of tension-type headache annually and/or more than one migraine attacks per month in the last year
  • •History of any other serious neurological, psychiatric, chronic pain disorders, or seizures
  • •History of bleeding diathesis, other bleeding disorders, or syncope with needle puncture
  • •History of cardiac arrhythmia or current pacemaker, neurostimulator, or other implanted stimulation device
  • •Recent or active substance use disorder
  • •Women who are currently pregnant, lactating, or planning to become pregnant during the study
  • •Any other medical conditions that could affect their ability to participate in acupuncture treatments for the study duration (as determined by study investigators)
  • •Active participation or past participation ≤3 months in any other interventional study.
  • •Unwilling to participate in all study related activities

Arms & Interventions

Low Dose

Experimental

Acupuncture treatment once per week for 5 weeks. Five total acupuncture treatments completed.

Intervention: Acupuncture (Procedure)

High Dose

Experimental

Acupuncture treatment twice per week for 5 weeks. Ten total acupuncture treatments completed.

Intervention: Acupuncture (Procedure)

Outcomes

Primary Outcomes

Change in Number of Headache Days

Time Frame: baseline to 3 months

The number of self-reported headache days over a 4 week period. Range: 0-28 days. More headache total days indicates a worse outcome.

Secondary Outcomes

  • Adverse Events(16 weeks)
  • Compliance With Overall Protocol(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials